"Incretins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Peptides which stimulate INSULIN release from the PANCREATIC BETA CELLS following oral nutrient ingestion, or postprandially.
| Descriptor ID |
D054795
|
| MeSH Number(s) |
D27.505.696.399.472.580
|
| Concept/Terms |
Incretins- Incretins
- Glucose-Dependent Insulin-Releasing Hormone
- Glucose Dependent Insulin Releasing Hormone
- Hormone, Glucose-Dependent Insulin-Releasing
- Insulin-Releasing Hormone, Glucose-Dependent
- Incretin
Incretin Effect- Incretin Effect
- Effect, Incretin
- Incretin Effects
- Effects, Incretin
|
Below are MeSH descriptors whose meaning is more general than "Incretins".
Below are MeSH descriptors whose meaning is more specific than "Incretins".
This graph shows the total number of publications written about "Incretins" by people in this website by year, and whether "Incretins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Incretins" by people in Profiles.
-
Small L, Ehrlich A, Iversen J, Ashcroft SP, Tro?t K, Moritz T, Hartmann B, Holst JJ, Treebak JT, Zierath JR, Barr?s R. Comparative analysis of oral and intraperitoneal glucose tolerance tests in mice. Mol Metab. 2022 03; 57:101440.
-
Lu VB, Rievaj J, O'Flaherty EA, Smith CA, Pais R, Pattison LA, Tolhurst G, Leiter AB, Bulmer DC, Gribble FM, Reimann F. Adenosine triphosphate is co-secreted with glucagon-like peptide-1 to modulate intestinal enterocytes and afferent neurons. Nat Commun. 2019 03 04; 10(1):1029.
-
Quarta C, Clemmensen C, Zhu Z, Yang B, Joseph SS, Lutter D, Yi CX, Graf E, Garc?a-C?ceres C, Legutko B, Fischer K, Brommage R, Zizzari P, Franklin BS, Krueger M, Koch M, Vettorazzi S, Li P, Hofmann SM, Bakhti M, Bastidas-Ponce A, Lickert H, Strom TM, Gailus-Durner V, Bechmann I, Perez-Tilve D, Tuckermann J, Hrabe de Angelis M, Sandoval D, Cota D, Latz E, Seeley RJ, M?ller TD, DiMarchi RD, Finan B, Tsch?p MH. Molecular Integration of Incretin and Glucocorticoid Action Reverses Immunometabolic Dysfunction and Obesity. Cell Metab. 2017 Oct 03; 26(4):620-632.e6.
-
Singh S, Wright EE, Kwan AY, Thompson JC, Syed IA, Korol EE, Waser NA, Yu MB, Juneja R. Glucagon-like peptide-1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Obes Metab. 2017 02; 19(2):228-238.
-
Viby NE, Isidor MS, Buggeskov KB, Poulsen SS, Hansen JB, Kissow H. Glucagon-like peptide-1 (GLP-1) reduces mortality and improves lung function in a model of experimental obstructive lung disease in female mice. Endocrinology. 2013 Dec; 154(12):4503-11.
-
Arora S, Mehrotra A, Gulati SC. Incretins and thiazolidinediones in glucose homeostasis and cancer: role of common polymorphisms. Cancer Lett. 2012 Oct 28; 323(2):128-34.
-
Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D. Diabetes and cancer: a consensus report. CA Cancer J Clin. 2010 Jul-Aug; 60(4):207-21.